Key facts
- SilverArc Capital Management is a hedge fund based in Boston, Massachusetts with 4 tracked portfolio companies.
- Notable positions include CORXEL Pharmaceuticals, Manifold, Congruence Therapeutics, Modulight Biotherapeutics.
- The team roster lists 2 people.
- SilverArc Capital Management reports $1.1B in regulatory assets under management across 3 private funds, per its SEC Form ADV (2026-03).
About SilverArc Capital Management
Founded in 2012, SilverArc Capital Management is a hedge fund manager based in Boston, Massachusetts. The firm seeks to invest in healthcare, drug companies, biotechnology, specialty pharmaceuticals, drug manufacturers, pharmaceutical, medical device, medical diagnostic, and life sciences companies across the United States. The firm's investment strategies include long/short and sector-oriented investment strategies. The firm's asset exposure includes equities, derivatives, fixed income, and foreign currencies. The firm's style preferences include volatility, small-cap, and mid-cap style preferences.
Registered with the SEC
Form ADV · 2026-03 · CRD 304220- Regulatory AUM
- $1.1B
- Private fund assets
- $935.3M
- Private funds
- 3 · 1 venture, 2 hedge
- Staff
- 9
- Registered office
- BOSTON, MA
- SEC status
- Approved
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as SILVERARC CAPITAL MANAGEMENT, LLC).
- ·Watchlist + alerts for SilverArc Capital Management's activity
Portfolio, priced
4 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| CORXEL Pharmaceuticals | Drug Discovery | $474.9M | — | |
| Manifold | — | $121.5M | — | |
| Congruence Therapeutics | — | — | — | |
| Modulight Biotherapeutics | — | — | — |
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does SilverArc Capital Management invest in?
- SilverArc Capital Management has 4 recorded portfolio companies, including CORXEL Pharmaceuticals, Manifold, Congruence Therapeutics, Modulight Biotherapeutics.
- What is SilverArc Capital Management's AUM?
- SilverArc Capital Management manages approximately $1.0B in assets.